Position in FBLG
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$103,168
+$81,484 QoQ
Shares Held
108,828
+562.5% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 15 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FBLG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cascade Financial Partners, LLC holds $131,128 across 2 Biotechnology names. FBLG ranks #1 (78.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FBLG |
FibroBiologics, Inc.
This page
|
108,828 | $103,168 | |
| 2 | PLX |
Protalix BioTherapeutics, Inc.
|
12,000 | $27,960 |
All Filings in FBLG
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,168 | 108,828 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $21,684 | 16,428 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $70,780 | 314,581 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $162,752 | 298,081 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $180,741 | 290,581 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $234,072 | 260,081 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $565,202 | 282,601 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $935,037 | 302,601 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,572,124 | 315,055 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||